Table 2 DVH metrics for DeliDose, CliDose, and PreDose in Eclipse TPS.

From: Evaluation of deliverable artificial intelligence-based automated volumetric arc radiation therapy planning for whole pelvic radiation in gynecologic cancer

Eclipse DVH parameters

Structure name

DVH metric

PreDose

DeliDose

CliDose

P-value

(PreDose vs. DeliDose)

P-value

(DeliDose vs. CliDose)

P-value

(PreDose vs. CliDose)

  

Mean ± SD

Mean ± SD

Mean ± SD

   

Body

Dmax (%)

106.5 ± 0.1

108.9 ± 0.9

107.7 ± 0.4

< 0.001

0.011

< 0.001

PTV

D50% (%)

99.9 ± 0.0

100.0 ± 0.0

100.0 ± 0.0

< 0.001

1.000

< 0.001

 

D98% (%)

93.2 ± 0.5

94.8 ± 0.4

95.1 ± 0.2

< 0.001

0.076

< 0.001

 

D95% (%)

94.9 ± 0.4

96.4 ± 0.4

96.4 ± 0.2

< 0.001

0.496

< 0.001

 

D2% (%)

103.2 ± 0.3

104.1 ± 0.2

103.6 ± 0.1

< 0.001

0.001

0.001

OL_PTV_Bowel

Dmax (%)

106.5 ± 0.1

104.8 ± 1.3

105.0 ± 1.3

0.026

0.734

0.075

Rectum

V40Gy (%)

58.7 ± 15.6

61.2 ± 15.6

65.1 ± 11.8

0.571

0.623

0.473

 

V50Gy (%)

6.8 ± 5.1

7.4 ± 6.8

11.0 ± 7.7

0.910

0.212

0.212

 

Dmax (%)

105.4 ± 0.7

102.4 ± 0.8

102.7 ± 0.8

< 0.001

0.473

< 0.001

Bladder

V45Gy (%)

46.9 ± 10.1

52.4 ± 11.2

51.1 ± 8.4

0.186

0.850

0.212

 

Dmax (%)

106.3 ± 0.3

102.7 ± 1.1

103.0 ± 0.7

< 0.001

0.384

< 0.001

Bowel Bag

V40Gy (%)

23.1 ± 5.3

22.9 ± 5.5

23.5 ± 5.1

0.734

0.623

0.850

PelvicBones

V10Gy (%)

89.7 ± 2.3

88.1 ± 2.9

85.5 ± 1.8

0.345

0.031

0.002

 

V40Gy (%)

27.6 ± 2.6

30.7 ± 3.1

26.8 ± 2.2

0.026

0.009

0.345

Femoral Joint

V30Gy (%)

3.5 ± 2.6

6.3 ± 4.3

2.0 ± 1.1

0.104

0.007

0.257

  1. Dmax: maximal dose; D50%: dose administered to 50% of volume; D98%: dose administered to 98% of volume; D95%: dose administered to 95% of volume; D2%: dose administered to 2% of volume; PTV: planning target volume; OL_PTV_Bowel: common area of PTV and Bowel Bag.
Back to article page